Delivery Order SPE2DR25D9143-SPE2DR26FRDK4
Award Date 1/13/26
Potential Completion Date 2/4/26
Potential Value $2.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,174.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% vials (4mL). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating the contractor competed in an unrestricted procurement. This delivery...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% vials (4 mL) with a contract value of $2,391.60. This firm fixed-price delivery order was awarded on September 5, 2025, with an ultimate completion date of September 26, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,881.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% Vial 4ML. This firm fixed-price delivery order, issued on November 28, 2025, with an ultimate completion date of December 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a $2,391.60 delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for Omidria 1-0.3% vial 4ML, a pharmaceutical product used during ophthalmic surgery. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $7,174.74 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025, for the supply of Omidria 1-0.3% vials (4ML). This delivery order is issued under the company's larger single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which...
- This contract award, valued at $4,983.96, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product OMIDRIA 1-0.3% VIAL 4ML, with an ultimate completion date of July 22, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,737.97, is for the delivery of OMIDRIA 1-0.3% vial, 4 mL, a pharmaceutical product. The contract has a firm fixed price and no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $9,566.32 contract is for the delivery of OMIDRIA 1-0.3% VIAL 4ML, a medical supply, with a completion date of June 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Omidria 1-0.3% Vial 4ML. The delivery order has a potential value of $5,753.55 and a completion date of December 11, 2023. DMS Pharmaceutical Group will supply the pharmaceutical item to DLA Troop Support Medical facilities from its place of performance in Park Ridge, Illinois. As a woman-owned small business and pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order for $4,544.76 to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4555071729 OMIDRIA 1-0.3% VIAL 4ML, with an anticipated completion date of October 28, 2021. No set-aside designation was used for this procurement. DMS Pharmaceutical Group Inc. will deliver the requested pharmaceutical products to the agency's location in Park Ridge by the scheduled completion date. The Defense...